January 22, 2024 C-Path’s TRxA Announces its 2024 Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced...
April 17, 2024-April 18, 2024 2024 Clinical Outcome Assessment Program Annual Meeting On April 17-18, 2024, the 2024 Clinical Outcome Assessment Annual Meeting...
January 11, 2024 C-Path to Lead New Task Force Aimed at Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases Critical Path Institute (C-Path) today announced the launch of a task force focused on accelerating drug...
February 8, 2024 TRxA 2024 Funding Opportunities Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is proud to announce its 2024 global...
January 9, 2024 Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes This webinar presents an overview of the published article in the Journal of the Society for Clinical Data Management that...
January 9, 2024 C-Path Appoints Dr. Klaus Romero as New CEO Longtime quantitative medicine and regulatory science expert to spearhead C-Path's collaborative efforts in accelerating...
November 16, 2023 eCOA Holds Annual Meeting in Denmark C-Path’s eCOA Consortium convened in Copenhagen, Denmark for its EU face-to-face meeting on Thursday, November 16. The eCOA...
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective The Critical Path Institute convened the Support Flexible Approaches to PRO Data Collection project as part of the eCOA: Gettin
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective